Location History:
- Saunders Town, RI (US) (2010)
- Wakefield, RI (US) (2008 - 2016)
- Irvine, CA (US) (2017 - 2024)
Company Filing History:
4 out of 78 
2 out of 41 
2 out of 9 
Years Active: 2008-2024
Title: Keykavous Parang: Innovator in Cancer Treatment
Introduction
Keykavous Parang is a prominent inventor based in Irvine, California, known for his significant contributions to cancer treatment through innovative drug delivery systems. With a total of nine patents to his name, Parang has made strides in the field of pharmaceuticals, particularly in the development of targeted therapies.
Latest Patents
Among his latest patents, Parang has developed APE/REF1 inhibitors for the treatment of cancer. These inhibitors target Apurinic/apyrimidinic endonuclease 1/Redox Factor-1 (APE/Ref-1) and include methods for their use. The structure of the inhibitor is defined by Formula I, where 'n' is an integer ranging from 4 to 14, and both 'X' and 'X'' can be either H or OH, while 'Y' and 'Y′' are also independently H or OH. Additionally, he has created targeted peptide-drug conjugates, which are drug delivery systems that combine a peptide targeting agent with a pharmaceutical agent for the effective delivery of chemotherapeutic agents. These innovations also encompass methods for treating cancer through the administration of the disclosed drug delivery systems.
Career Highlights
Throughout his career, Keykavous Parang has held positions at notable institutions, including the Board of Governors for Higher Education in the State of Rhode Island and